trending Market Intelligence /marketintelligence/en/news-insights/trending/Gtyby06RjpR79-5ou9GbAQ2 content esgSubNav
In This List

PhotoMedex to appeal Nasdaq delisting decision

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


PhotoMedex to appeal Nasdaq delisting decision

PhotoMedex Inc. said it would appeal a Nasdaq decision to delist its shares from the stock exchange.

The company has until 4 p.m. ET on May 30 to appeal the decision, which would stay the delisting until after the appeal is heard. Otherwise, the company's securities will be suspended at the opening of business June 1.

While the company met the stock exchange's continued listing requirements, it failed to submit an initial listing application after completing an agreement with First Capital Real Estate Trust Inc.

As a result, the company's stock again fell out of compliance and Nasdaq determined to delist PhotoMedex's securities — a decision the company will now appeal.